Which hedge funds own CLYM? CLIMB BIO INC, Q2 2026 13F holders
29 tracked hedge funds disclosed a position in CLYM (CLIMB BIO INC) in their Q2 2026 13F filings, worth $397.7m in total. The largest holder by portfolio weight is Superstring Capital Management LP at 4.3% of its book. 13 opened a new position this quarter: Ally Bridge Group (NY) LLC, Stempoint Capital LP, Cormorant Asset Management, LP, Redmile Group, LLC. 14 exited: MPM Bioimpact LLC, Diadema Partners LP, Silverarc Capital Management, LLC.
- 29
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 13
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 14
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $124m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $40.0m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $398m
- Combined value Sum of the holders' reported positions in the security.
- 2.3%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| MPM Bioimpact LLC | 1.4% | $17.8m |
| Diadema Partners LP | 0.8% | $2.0m |
| Silverarc Capital Management, LLC | 0.6% | $4.7m |
| Kynam Capital Management, LP | 0.4% | $6.9m |
| Seven Fleet Capital Management LP | 0.3% | $895k |
| Persistent Asset Partners Ltd | 0.2% | $495k |
| 683 Capital Management, LLC | 0.06% | $617k |
| Fox Run Management, L.L.C. | 0.02% | $126k |
| Diametric Capital, LP | 0.02% | $76.8k |
| Marshall Wace, LLP | 0.01% | $5.3m |
| Brevan Howard Capital Management LP | 0.0% | $388k |
| Hudson Bay Capital Management LP | 0.0% | $373k |
| Point72 Asset Management, L.P. | 0.0% | $405k |
| Balyasny Asset Management L.P. | 0.0% | $47.7k |
Ownership over time
Who discovered CLYM first? Beta
The run: Q2 2025 → Q2 2026, +952%
| Affinity Asset Advisors, LLC | Q2 2024 | 0.3% | −0.4 pts |
| RA Capital Management, L.P. | Q2 2024 | 0.7% | −2.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.